Zanubrutinib in Relapsed or Refractory MCL

Zanubrutinib in Relapsed or Refractory MCL

User Photo
obr

6 months
7 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
John Burke, MD Physician, Associate Chair, US Oncology Hematology Research Program, Medical Oncology/ Hematology, Rocky Mountain Cancer Centers outlines the patient profile that is best suited for zanubrutinib in relapsed or refractory mantle cell lymphoma (MCL)
Up Next Autoplay
User Photo